Tumour necrosis factor (TNF) inhibitors are an effective option in the management of Crohn's disease

Author：  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.26, Iss.9, 2010-09, pp. : 15-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimizing the Use of Tumour Necrosis Factor Inhibitors in Crohn's Disease: A Practical Approach

By >   Ordás Ingrid   Ricart Elena  

Drugs, Vol. 70, Iss. 2, 2010-01 ,pp. : 109-120

Adis International

Access to resources Recommend Favorite

The Future Role of Anti-Tumour Necrosis Factor- Products in the Treatment of Crohn's Disease

By van Hogezand R.A.   Verspaget H.W.  

Drugs, Vol. 56, Iss. 3, 1998-09 ,pp. : 299-305

Adis International

Access to resources Recommend Favorite

Leukaemic Transformation in Patients with Haematological Disease Receiving Tumour Necrosis Factor Inhibitors

By Ferrer-Marín Francisca   >   Vicente Vicente  

Clinical Drug Investigation, Vol. 32, Iss. 6, 2012-06 ,pp. : 423-426

Adis International

Access to resources Recommend Favorite

Immunosuppressants/tumour necrosis factor inhibitors: Legionnaires' disease: 24 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1385, 2012-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite

Tumour necrosis factor- blockade: a new era for effective management of rheumatoid arthritis

By Hamilton K.   St. Clair E.W.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 5, 2000-07 ,pp. : 1041-1052

Informa Healthcare

Access to resources Recommend Favorite